Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653106 · ClinicalTrials.gov registry record · NA
Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT01653106 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 148 participants.
The verdict
NCT01653106, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of short-term (2 hours/120 minutes) and long-term (6 hours/360 minutes) schedules of crushed ice therapy (cryotherapy). Patients that receive high dose melphalan for bone marrow transplantation commonly develop significant mouth pain and sores (oral mucositis) unless cryotherapy is utilized. The goal of this study is to scientifically determine (using randomization and a larger sample size) if a short-term schedule is as effective as the standard long-term schedule in preventing, or minimizing the symptoms involved with oral mucositis. The study is also trying to determine the best dose of melphalan and how patient's body breaks down melphalan and will obtain blood through central venous catheter to measure the amount of melphalan in patient's blood at specific times after the melphalan is infused
Interventions
- OTHER questionnaire administration
- OTHER pharmacological study
- PROCEDURE cryotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653106
The ClinicalTrials.gov registry entry for NCT01653106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01653106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653106 about?
NCT01653106 is a clinical study titled "Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients". The purpose of this study is to compare the effect of short-term (2 hours/120 minutes) and long-term (6 hours/360 minutes) schedules of crushed ice therapy (cryotherapy). Patients that receive high dose melphalan for bone marrow transplantation commonly develop significant mouth pain and sores (oral...
What is the current status of trial NCT01653106?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2012-04. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01653106?
The interventions under investigation include: questionnaire administration (OTHER), pharmacological study (OTHER), cryotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT01653106?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.